Ann D Thor
Physician at Dorado Pl, Englewood, CO
License number
Colorado 44903
Issued Date
Jul 24, 2006
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
6605 E Dorado Pl, Englewood, CO 80111
Professional information
Perinucleolar Compartment As A Cancer Marker
US Patent:
8241862, Aug 14, 2012
Filed:
Sep 15, 2009
Appl. No.:
12/559634
Inventors:
Sui Huang - Chicago IL, US
Rajesh V. Kamath - Shrewsbury MA, US
David L. Spector - Cold Spring Harbor NY, US
Ann D. Thor - Greenwood Village CO, US
Chen Wang - Chicago IL, US
Rajesh V. Kamath - Shrewsbury MA, US
David L. Spector - Cold Spring Harbor NY, US
Ann D. Thor - Greenwood Village CO, US
Chen Wang - Chicago IL, US
Assignee:
Northwestern University - Evanston IL
Cold Spring Harbor Laboratory - Cold Spring Harbor NY
Cold Spring Harbor Laboratory - Cold Spring Harbor NY
International Classification:
G01N 33/574
US Classification:
435 723, 435 71
Abstract:
The present invention relates to compositions and methods for cancer diagnostics, prognostics and predictions, including but not limited to, cancer markers. In particular, the present invention provides perinucleolar compartments and their resident molecules as cancer markers.
Perinucleolar Compartment As A Cancer Marker
US Patent:
2012030, Dec 6, 2012
Filed:
Aug 14, 2012
Appl. No.:
13/584921
Inventors:
Sui Huang - Chicago IL, US
Rajesh V. Kamath - Shrewsbury MA, US
David L. Spector - Cold Spring Harbor NY, US
Ann D. Thor - Greenwood Village CO, US
Chen Wang - Chicago IL, US
Rajesh V. Kamath - Shrewsbury MA, US
David L. Spector - Cold Spring Harbor NY, US
Ann D. Thor - Greenwood Village CO, US
Chen Wang - Chicago IL, US
Assignee:
COLD SPRING HARBOR LABORATORY - Cold Spring Harbor NY
NORTHWESTERN UNIVERSITY - Evanston IL
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
G01N 33/574, G01N 33/577
US Classification:
435 71
Abstract:
The present invention relates to compositions and methods for cancer diagnostics, prognostics and predictions, including but not limited to, cancer markers. In particular, the present invention provides perinucleolar compartments and their resident molecules as cancer markers.